1880 Sismet Road Mississauga, ON L4W 1W9, Canada

+1 905-212-9482

RESEARCH & CLINICAL
TRIALS AT OCC EYECARE

Research Excellence comes out of our research division, The Canadian Centre for Advanced Eye Therapeutics, which focuses on clinical research as well as utilizing the most advanced technology available for the management of complex eye diseases. Through this research, academia, and development, we are able to speed innovation and make medicines, treatments, and surgical techniques more readily available to improve patients’ vision and overall health.

RECRUITING TRIALS

We are actively recruiting patients for Wet AMD, DME, RVO, and Glaucoma.

Eligibility:

Volunteer must be:

50 years of age or older.
Capable of giving written informed consent to participate.
Willing to visit our facility for all scheduled visits during the study.
Confirmed evidence of AMD, DME, RVO, or Glaucoma, depending on study.

If you are interested to learn more information and have answered yes to all the above questions, please contact us to arrange an appointment. Other eligibility criteria will apply and will be discussed thoroughly before your decision to participate or not.

ONGOING TRIALS

GlaxoSmithKline BAM114341

A phase 2, multi-centre, randomized, double-masked, placebo-controlled, parallel-group study to investigate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of GSK933776 in adult patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Dr. Narendra Armogan / Dr. Fareed Ali

Alcon C10-041

Efficacy and Safety of Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL Eye Drops, Suspension Compared to Brinzolamide 10 mg/mL Eye Drops, Suspension plus Brimonidine 2 mg/mL Eye Drops, Solution in Patients with Open-Angle Glaucoma.

Dr. David B. Yan / Dr. Dan D. DeAngelis

Novartis RESPOND CRFB002DCA05

A Canadian, 12 month, prospective, randomized, open-label, multicenter, laser controlled phase IIIb study assessing the efficacy, safety and cost efficacy of ranibizumab as combination and monotherapy in patients with visual impairment due to diabetic macular edema.

Dr. Fareed Ali / Dr. Narendra Armogan

BauschB+Lomb 650

A prospective multicenter clinical trial to evaluate the effectiveness of a toric accommodating posterior chamber silicone intraocular lens designed to provide near, intermediate and distance vision & reduce the effects of preoperative corneal astigmatism on post operative refraction following cataract surgery.

Dr. Narendra Armogan / Dr. David B. Yan / Dr. Dan D. DeAngelis

Novartis HOLOGRAM

High resolution/spectral-domain OCT (SD-OCT) monitoring in patients with choroidal neovascularization secondary to age-related macular degeneration (AMD), a Ranibizumab (Lucentis) outcomes pilot program.

Dr. Fareed Ali / Dr. Narendra Armogan

BauschB+Lomb 650

A prospective multicenter clinical trial to evaluate the effectiveness of a toric accommodating posterior chamber silicone intraocular lens designed to provide near, intermediate and distance vision & reduce the effects of preoperative corneal astigmatism on post operative refraction following cataract surgery.

Dr. Narendra Armogan / Dr. David B. Yan / Dr. Dan D. DeAngelis

OCC EYECARE CENTRE LOCATIONS

Our specialized team of doctors and state-of-the-art facility
are available at two convenient locations

1880 Sismet Road Mississauga,
ON L4W 1W9, Canada

+1 905-212-9482

2630 Rutherford Rd #105, Vaughan,
ON L4K 0H2, Canada

+1 (905) 212-9482

Buy the best eye products available!